What I truly liked about the new MFIC interview on www.WallSt.net is how the CEO repeated that the co. is enabling the nanotechnology revolution through the efficient manufacturing of small, uniform nanoparticles and nanostructures. He indicated that the backlog is presently over $4 Million and that they expect a "significant" increase in the current quarter. I was glad to hear him elaborate on their two existing nanotech collaborations. The first is with UMass-Lowell in which MFIC's equipment is the centerpiece of this nanotech manufacturing center and gets great exposure to potential customers including companies at the "seed" level. The second collaboration is with a "food ingredient co." for food processing technologies including developing low fat materials, adding nutriceuticals to improve the nutritional value of food products and developing soy protein to make soy milk taste like regular milk. It was mentioned that MFIC's products are being sold to the Far East including China, Japan, Thailand, etc. and they have labs in Boston, California and Germany. Regarding the MMR systems for continuous chemical reactions, the CEO is standing by his prediction that this product was designed to serve a very large market and that it can produce chemical reactions in a revolutionary way. It is a disruptive technology that replaces reactive batch technology and if their plan comes to fruition the company can grow to the $35 Million to $100 Million sales range through internal growth and/or a small acquisition. MFIC plans to acheive 15%+ pre-tax profits and still will seek a national exchange listing when the time is right.
AI
